Skip to content

Efficacy of Shulaghna Saptak Vati in post operative pain management

Clinical Efficacy of Shulaghna Saptak Vati in post operative pain management after open Haemorrhoidectomy- A Randomized Controlled Clinical Trial - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/084845
Enrollment
40
Registered
2025-04-15
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K642- Third degree hemorrhoids

Interventions

None listed

Sponsors

Institute of Teaching and Research in Ayurveda, Jamnagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Post-open patient of Open haemorrhoidectomy with complaints of pain between the age group 18-60 years

Exclusion criteria

Exclusion criteria: 1. Age less than 18 years and more than 60 years. 2. Patients who underwent operation for hemorrhoid associated with fissure or fistula-in-ano, who is having complications like bleeding from the operated site and surgical site infection IBS OR diagnosed cases Crohn s disease, in immunocompromised states like HIV, HbsAg, VDRL, HCV 3. Known cases of Malignancy, Tuberculosis. 4. Uncontrolled Hypertension (diastolic BP greater than 90mmHg, Systolic BP greater than 160mmHg), uncontrolled Diabetes Mellitus (FBS greater than 110mg/dl, PPBS greater than 140mg/dl), Cardiac disorders. 5. Pregnant and lactating woman.

Design outcomes

Primary

MeasureTime frame
Relief in the post operative pain of open haemorrhoidectomy patientsTimepoint: 1st day and 7th day

Secondary

MeasureTime frame
Absence of recurrence of pain in the folllow up periodTimepoint: 22nd day

Countries

India

Contacts

Public ContactProf Dr T S DUDHAMAL

Institute of Teaching and Research in Ayurveda, Jamnagar

drtsdudhamal@gmail.com9745362889

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026